SEC Form 4 · accession 0001456817-26-000011
TELA Bio, Inc. · TELA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph H Capper
Director
Period of report
Jul 15, 2026
Accepted (ET)
Jul 17, 2026 · 5:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001561921
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 15, 2026 | A | 6,227 | $0.785 | A | 29,827 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of common stock issued in lieu of cash compensation under the Issuer's Amended and Restated Non-Employee Director Compensation Policy. All shares are fully vested.